Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The backlash against bioequivalence and the interchangeability of brand-name and generic drugs.

The backlash against bioequivalence and the interchangeability of brand-name and generic drugs. CMAJ. 2011 Sep 06; 183(12):1350-1.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.